Kontostathi Georgia, Makridakis Manousos, Bitsika Vasiliki, Tsolakos Nikolaos, Vlahou Antonia, Zoidakis Jerome
Biomedical Research Foundation Academy of Athens, Athens, Greece.
ProtATonce, NCSR Demokritos, Athens, Greece.
Methods Mol Biol. 2019;1959:205-223. doi: 10.1007/978-1-4939-9164-8_14.
Selected/multiple reaction monitoring-mass spectrometry (SRM/MRM) is an analytical method that is frequently combined to the use of stable isotope-labeled standard (SIS) peptides for absolute protein quantification. The application of SRM/MRM is a relatively recent development in the proteomics field for analysis of biological samples (plasma, urine, cell/tissue lysates) targeting to a large extent biomarker validation. Although MRM generally by-passes the use of antibodies (being linked to sub-optimal assay specificity in many cases), bioanalytical validation of MRM protocols has not been robustly applied because of sensitivity issues, in contrary to antibody-based methods. In this chapter, we will discuss the points that should be addressed for MRM method development in clinical proteomics applications.
选择反应监测/多反应监测质谱法(SRM/MRM)是一种分析方法,常与稳定同位素标记标准肽(SIS)结合用于蛋白质绝对定量。SRM/MRM的应用是蛋白质组学领域中相对较新的进展,用于分析生物样品(血浆、尿液、细胞/组织裂解物),在很大程度上旨在验证生物标志物。尽管MRM通常无需使用抗体(在许多情况下抗体与次优的分析特异性相关),但由于灵敏度问题,与基于抗体的方法相反,MRM方案的生物分析验证尚未得到有力应用。在本章中,我们将讨论临床蛋白质组学应用中MRM方法开发应解决的要点。